In focus · trending topic

ERK inhibitor

64 stories · following the connections

Kura Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update

By Nasdaq OMXMay 8, 2018, 8:05 PM UTC

Kura Oncology to Present at Deutsche Bank 43rd Annual Health Care Conference

By Nasdaq OMXMay 3, 2018, 11:30 AM UTC

Kura Oncology Announces New Patent for Tipifarnib in Hematologic Malignancies

By Nasdaq OMXMay 2, 2018, 11:31 AM UTC

Kura Oncology to Report First Quarter 2018 Financial Results

By Nasdaq OMXMay 1, 2018, 11:30 AM UTC

Kura Oncology Announces Upcoming Presentations at AACR Annual Meeting 2018

By Nasdaq OMXApr 9, 2018, 11:30 AM UTC

Kura Oncology Provides Regulatory Update on Tipifarnib and Reports Fourth Quarter and Full Year 2017 Financial Results

By Nasdaq OMXMar 12, 2018, 8:05 PM UTC

Kura Oncology to Present at Cowen and Company 38th Annual Health Care Conference

By Nasdaq OMXMar 6, 2018, 12:30 PM UTC

Kura Oncology to Report Fourth Quarter and Full Year 2017 Financial Results

By Nasdaq OMXMar 5, 2018, 9:05 PM UTC